What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD?¶
Notebook ID: nb-SDA-2026-04-25-gapdebate-e849205bca · Analysis: SDA-2026-04-25-gapdebate-e849205bca
Domain: neurodegeneration · Date: 2026-04-25
Research Question¶
Despite being the core debate question, causality remains unresolved due to reliance on cross-sectional human data and artificial animal models. The expert noted this chicken-and-egg problem prevents optimal therapeutic targeting strategies.
Source: Debate session sess_SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d (Analysis: SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d)
Debate Summary¶
Debate transcript not available for this analysis.
Hypotheses Ranked by Composite Score¶
Total hypotheses: 7
| Title | Composite | Confidence | Novelty | Feasibility | Impact |
|---|---|---|---|---|---|
| Endosomal trafficking defects are the common upstream lesion linking APP process | 0.73 | 0.82 | 0.74 | 0.71 | 0.78 |
| Temporal order is subtype-specific rather than universal | 0.73 | 0.76 | 0.66 | 0.83 | 0.81 |
| APOE4-microglial complement signaling causes cholinergic-enriched synaptic vulne | 0.63 | 0.67 | 0.62 | 0.69 | 0.66 |
| Locus coeruleus degeneration gates whether cholinergic dysfunction or amyloid/ta | 0.62 | 0.58 | 0.61 | 0.8 | 0.49 |
| Basal forebrain NGF/TrkA trophic failure is an upstream trigger that makes choli | 0.61 | 0.65 | 0.68 | 0.6 | 0.72 |
| Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-de | 0.45 | 0.46 | 0.42 | 0.64 | 0.38 |
| Reactive astrocytes and cholinesterase-rich low-acetylcholine niches amplify tau | 0.44 | 0.34 | 0.5 | 0.56 | 0.36 |
Knowledge Graph Edges¶
No KG edges found for this analysis.
Key Citations¶
No citations found for this analysis.